scholarly journals Efficacy of steroidal vs non-steroidal agents in oral lichen planus: a randomised, open-label study

2016 ◽  
Vol 131 (1) ◽  
pp. 69-76 ◽  
Author(s):  
A R Singh ◽  
A Rai ◽  
M Aftab ◽  
S Jain ◽  
M Singh

AbstractObjective:This study compared the therapeutic efficacy of steroidal and non-steroidal agents for treating oral lichen planus.Methods:Forty patients with clinical and/or histologically proven oral lichen planus were randomly placed into four groups and treated with topical triamcinolone, oral dapsone, topical tacrolimus or topical retinoid for three months. Pre- and post-treatment symptoms and signs were scored for each patient.Results:Patients in all treatment groups showed significant clinical improvement after three months (p < 0.05), with steroidal and non-steroidal agents having equal efficacy. Furthermore, of the non-steroidal drugs, oral dapsone had greater efficacy than topical retinoid (p < 0.05). However, no significant differences in outcome were recorded for oral dapsone vs topical tacrolimus (p > 0.05) and for topical retinoid vs topical tacrolimus (p > 0.05).Conclusion:Non-steroidal drugs such as dapsone, tacrolimus and retinoid are as efficacious as steroidal drugs for treating oral lichen planus, and avoid the side effects associated with steroids.

2002 ◽  
Vol 46 (1) ◽  
pp. 35-41 ◽  
Author(s):  
F. Kaliakatsou ◽  
T.A. Hodgson ◽  
J.D. Lewsey ◽  
A.M. Hegarty ◽  
A.G. Murphy ◽  
...  

2012 ◽  
Vol 16 (4) ◽  
pp. 221-229 ◽  
Author(s):  
Michael Samycia ◽  
Andrew N. Lin

Background: Topical calcineurin inhibitors have been studied in many skin disorders, including lichen planus. Objective: To evaluate published reports of the use of topical calcineurin inhibitors in lichen planus. Methods: We searched PubMed, Ovid/Cochrane, and Embase using the keywords “tacrolimus,” “pimecrolimus,” “topical calcineurin inhibitors,” and “lichen planus.” Results: We examined 5 double-blind studies, 1 investigator-blinded study, 10 open prospective studies, 6 retrospective studies, and 28 case reports evaluating tacrolimus or pimecrolimus for oral, vulvovaginal, and cutaneous lichen planus. Conclusions: Strong evidence (double-blind and open studies) supports the use of topical tacrolimus ointment in oral lichen planus, with efficacy at least equal to topical clobetasol propionate 0.05% ointment. Treatment of oral lichen planus with topical tacrolimus ointment can result in demonstrable blood tacrolimus levels, but without clinically significant adverse events. Strong evidence (double-blind and open studies) supports the use of topical pimecrolimus 1% cream in oral lichen planus, with efficacy equal to that of topical triamcinolone acetonide 0.1% paste. For vulvovaginal lichen planus, pimecrolimus was superior to placebo in one double-blind study, and tacrolimus was effective in open studies. Only case reports support the efficacy of topical calcineurin inhibitors in cutaneous lichen planus.


2010 ◽  
Vol 39 (3) ◽  
pp. 201-205 ◽  
Author(s):  
Pía López-Jornet ◽  
Fabio Camacho-Alonso ◽  
Noemi Salazar-Sanchez

2004 ◽  
Vol 15 (5) ◽  
pp. 308-314 ◽  
Author(s):  
MA Thomson ◽  
J Hamburger ◽  
DG Stewart ◽  
HM Lewis

Sign in / Sign up

Export Citation Format

Share Document